Skip to main content
Sophie Paczesny, MD, Pediatric Hematology & Oncology, Indianapolis, IN

SophiePaczesnyMD

Pediatric Hematology & Oncology Indianapolis, IN

Cancer Genetics/Cancer Risk Assessment, Pediatric Hematologic Oncology

Associate Professor Indiana University School of Medicine

Dr. Paczesny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Paczesny's full profile

Already have an account?

  • Office

    1044 W. Walnut Street
    R4-425
    Indianapolis, IN 46202
    Phone+1 317-278-5487

Summary

  • Dr. Sophie Paczesny is a pediatric hematologist/oncologist in Indianapolis, IN. She received her medical degree from University of Paris VII Faculty of Medicine and has been in practice 21 years. She specializes in cancer genetics/cancer risk assessment and pediatric hematologic oncology.

Education & Training

  • University of Paris VII Faculty of Medicine
    University of Paris VII Faculty of MedicineClass of 1995

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value in Isolation or with Other Graft-Versus-Host Disease Symptoms as Currently Diagnos...  
    Margaret MacMillan, Sophie Paczesny, Ran Reshef, Daniel Weisdorf, Haematologica
  • From Proteomics to Discovery of First-in-Class ST2 Inhibitors Active in Vivo  
    Sophie Paczesny, MD, The Journal of Clinical Investigation

Abstracts/Posters

  • IL-33 Therapy Prevents Acute Lung Injury after Transplantation Via IL-9-Producing Type 2 Innate Lymphoid Cells Induction
    Sophie Paczesny, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • ST2 and ROR-Gamma-t Roles in Intestinal Regulatory T Cells 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Risk Biomarkers May Be Used to Anticipate Severe Stem Cell Transplant Adverse Effects: Research
    Risk Biomarkers May Be Used to Anticipate Severe Stem Cell Transplant Adverse Effects: ResearchMay 28th, 2023
  • Risk Biomarkers Could Predict Serious Side Effect of Stem Cell Transplant
    Risk Biomarkers Could Predict Serious Side Effect of Stem Cell TransplantMay 22nd, 2023
  • Golden Appointed to Diversity, Inclusion and Equity Committee
    Golden Appointed to Diversity, Inclusion and Equity CommitteeMarch 29th, 2021
  • Join now to see all